ERAP2 and inflammatory bowel disease: However, increased ERAP2 expression is in general associated with risk of chronic inflammatory diseases, including IBD (especially Crohn’s disease), ankylosing spondylitis, birdshot chorioretinopathy, psoriasis, preeclampsia, and hypertension [9–11].